Published in Transplant Rev on January 01, 1975
Oral tolerance. Immunol Rev (2005) 3.48
TGF-beta regulates in vivo expansion of Foxp3-expressing CD4+CD25+ regulatory T cells responsible for protection against diabetes. Proc Natl Acad Sci U S A (2004) 3.26
Human T regulatory cell therapy: take a billion or so and call me in the morning. Immunity (2009) 3.21
T-cell-mediated suppression of anti-tumor immunity. An explanation for progressive growth of an immunogenic tumor. J Exp Med (1980) 3.17
Oral tolerance. Immunol Rev (2011) 3.03
Blocking effect of lyt-2 antibodies on T cell functions. J Exp Med (1980) 2.15
'Yin-Yang' functions of transforming growth factor-beta and T regulatory cells in immune regulation. Immunol Rev (2007) 1.98
Suppressor-cell induction in vitro. IV. Target of antigen-specific suppressor factor and its genetic relationships. J Exp Med (1978) 1.77
Induction of cell-mediated immunity to Mycobacterium lepraemurium in susceptible mice. Infect Immun (1977) 1.67
The development and function of regulatory T cells. Cell Mol Life Sci (2009) 1.66
Delayed-type hypersensitivity to influenza virus. Induction of antigen-specific suppressor T cells for delayed-type hypersensitivity to hemagglutinin during influenza virus infection in mice. J Exp Med (1980) 1.54
TGF-beta and regulatory T cell in immunity and autoimmunity. J Clin Immunol (2008) 1.49
Immune responses to malignancies. J Allergy Clin Immunol (2010) 1.48
Conditions that induce tolerance in mature CD4+ T cells. J Exp Med (1997) 1.45
Primary and secondary abnormalities of T cell subpopulations. Clin Exp Immunol (1978) 1.43
Immune response in the mutant diabetic C57BL/Ks-dt+ mouse. Discrepancies between in vitro and in vivo immunological assays. J Clin Invest (1978) 1.35
Tolerance, the thymus, and suppressor T cells. Clin Exp Immunol (1977) 1.33
Impaired cell-mediated immunity in Hodgkin's disease mediated by suppressor lymphocytes and monocytes. J Clin Invest (1978) 1.31
The potential of human regulatory T cells generated ex vivo as a treatment for lupus and other chronic inflammatory diseases. Arthritis Res (2002) 1.30
Induction and mode of action of suppressor cells generated against human gamma globulin. I. An immunologic unresponsive state devoid of demonstrable suppressor cells. J Exp Med (1978) 1.29
Regulatory mechanisms in cell-mediated immune responses. IV. Expression of a receptor for mixed lymphocyte reaction suppressor factor on activated T lymphocytes. J Exp Med (1976) 1.27
Binding to idiotypic determinants of large proportions of thymus-derived lymphocytes in idiotypically suppressed mice. Proc Natl Acad Sci U S A (1977) 1.26
Mechanisms of suppression of cytotoxic T-cell responses in murine lymphocytic choriomeningitis virus infection. J Exp Med (1977) 1.21
Soluble antigen abrogates the appearance of anti-protein IgG1-forming cell precursors during primary immunization. Proc Natl Acad Sci U S A (1990) 1.20
Alterations of the immune response associated with chronic experimental leishmaniasis. Infect Immun (1979) 1.20
Behaviour of human immunoregulatory cells in culture. I. Variables requiring consideration for clinical studies. Clin Exp Immunol (1979) 1.16
Generation of specfic T-cell suppressor function induced by Streptococcus mutans in monkeys and mice. Infect Immun (1979) 1.15
CD4 T cells in tumor immunity. Springer Semin Immunopathol (2005) 1.13
Alloantigen receptors on activated T cells in mice. I. Binding of alloantigens and anti-idiotypic antibodies to the same receptors. J Exp Med (1978) 1.12
Special regulatory T-cell review: Regulatory T cells and the intestinal tract--patrolling the frontier. Immunology (2008) 1.12
Heterogeneity of murine regulatory T cells. I. Subpopulations of amplifier and suppressor T cells. J Exp Med (1976) 1.11
Suppression of delayed hypersensitivity to tuberculin by antigenic competition. A positive immunoregulatory mechanism sensitive to cyclophosphamide. Immunology (1981) 1.09
Regulatory T cells: immune suppression and beyond. Cell Mol Immunol (2010) 1.09
In vitro cell response of Treponema pallidum-infected rabbits. III. Impairment in production of lymphocyte mitogenic factor. Clin Exp Immunol (1977) 1.07
Suppression of immunity to Mycobacterium lepraemurium infection. Infect Immun (1977) 1.04
Suppressor cells: dependence on assay conditions for functional activity. J Exp Med (1976) 1.02
Regulation generation: the suppressive functions of human regulatory T cells. Crit Rev Immunol (2012) 0.98
Suppressor cell-mediated neutropenia in Felty's syndrome. J Clin Invest (1978) 0.98
The lymphocyte mediators of delayed hypersensitivity: the early phase cells. Immunology (1978) 0.95
Demonstration of low-regulatory CD25High+CD4+ and high-pro-inflammatory CD28-CD4+ T-Cell subsets in patients with ulcerative colitis: modified by selective granulocyte and monocyte adsorption apheresis. Dig Dis Sci (2007) 0.95
Influence of splenectomy on first set rejection reactions of C57BL/6 females to male skin isografts. J Exp Med (1977) 0.89
Cell interactions in the suppression of in vitro antibody responses. J Exp Med (1976) 0.89
Dynamic ocular surface and lacrimal gland changes induced in experimental murine dry eye. PLoS One (2015) 0.89
Immunoregulatory properties of serum from patients with different stages of syphilis. Br J Vener Dis (1980) 0.88
Immunity by equilibrium. Nat Rev Immunol (2016) 0.88
Bone marrow suppressor B cells in vitro. Immunology (1978) 0.87
The regulation of T cell responses by spontaneously active suppressor cells. Clin Exp Immunol (1982) 0.87
On the feedback regulation of humoral immune response. I. Evidence for 'B suppressor cells'. Immunology (1979) 0.87
Transduction of an HLA-DP4-restricted NY-ESO-1-specific TCR into primary human CD4+ lymphocytes. J Immunother (2006) 0.87
The role of mucosal T lymphocytes in regulating intestinal inflammation. Springer Semin Immunopathol (2005) 0.85
Antagonistic interactions between enhancing and suppressor factors that regulate the humoral immune response. Immunology (1979) 0.84
Non-specific suppression of the initiation of the immune response to a heterologous immunogen by supernatants from specifically stimulated, primed lymphoid cells. Immunology (1977) 0.84
The expression profile of functional regulatory T cells, CD4+CD25high+/forkhead box protein P3+, in patients with ulcerative colitis during active and quiescent disease. Clin Exp Immunol (2009) 0.82
Immunological regulation of spontaneous antibodies to DNA and RNA. III. Early effects of neonatal thymectomy and splenectomy. Immunology (1977) 0.82
Differences in behavior and prognosis between leukemic and lymphomatous forms of a transplantable hamster lymphocytic neoplasm induced by simian virus 40. Proc Natl Acad Sci U S A (1978) 0.81
Experimental myocardial infarction induces altered regulatory T cell hemostasis, and adoptive transfer attenuates subsequent remodeling. PLoS One (2014) 0.80
Busulfan and chloramphenicol induced T cell lymphoma: cell surface characteristics and functional properties. Clin Exp Immunol (1986) 0.79
Partial characterization of a T cell-derived factor that suppresses the initiation of the humoral immune response in vitro. Immunology (1977) 0.79
Transplantation tolerance: Clinical potential of regulatory T cells. Self Nonself (2011) 0.79
Viral abrogation of lymphocyte mitogenesis: induction of a soluble factor inhibitory to cellular proliferation. Immunology (1980) 0.78
Differences in the maturation of the immune response of A- and A+ rabbits. Good and poor responders respectively for the A antigen. Immunology (1977) 0.77
Mechanisms of idiotype suppression. IV. Functional neutralization in mixtures of idiotype-specific suppressor and hapten-specific suppressor T cells. J Exp Med (1981) 0.77
IL-12 and IL-4 activate a CD39-dependent intrinsic peripheral tolerance mechanism in CD8(+) T cells. Eur J Immunol (2016) 0.76
D-penicillamine: a modulator of anti-DNA antibodies production. Clin Exp Immunol (1986) 0.75
Selective Sparing of Human Tregs by Pharmacologic Inhibitors of the Phosphatidylinositol 3-Kinase and MEK Pathways. Am J Transplant (2016) 0.75
Microbe-induced lymphocyte blastogenesis enhancement after preculture. Infect Immun (1985) 0.75
Systemic lupus erythematosus--an autoimmune disease? J Clin Pathol Suppl (R Coll Pathol) (1978) 0.75
Regulation of immune response to SRBC: suppressor cell activity induced by soluble fraction of antigen. Immunology (1978) 0.75
T cell control of antibody production. Contemp Top Immunobiol (1974) 8.38
Potentiation of the T-lymphocyte response to mitogens. I. The responding cell. J Exp Med (1972) 6.52
Immunoregulatory circuits among T-cell sets. I. T-helper cells induce other T-cell sets to exert feedback inhibition. J Exp Med (1978) 6.29
Cell interactions in the induction of tolerance: the role of thymic lymphocytes. Immunology (1970) 6.06
Immunoregulatory circuits among T-cell sets. II. Physiologic role of feedback inhibition in vivo: absence in NZB mice. J Exp Med (1978) 5.48
Augmentation of delayed-type hypersensitivity by doses of cyclophosphamide which do not affect antibody responses. J Exp Med (1975) 5.42
Infectious immunological tolerance. Immunology (1971) 5.30
Suppressor T cells. J Immunol (1972) 3.92
Immunological circuits: cellular composition. Fed Proc (1979) 3.72
Cell-mediated immunity: delayed-type hypersensitivity and cytotoxic responses are mediated by different T-cell subclasses. J Exp Med (1976) 3.21
Requirement for vasoactive amines for production of delayed-type hypersensitvity skin reactions. J Exp Med (1975) 2.91
Contrasuppression. A novel immunoregulatory activity. J Exp Med (1981) 2.84
Immunoregulatory circuits among T-cell sets. Identification of a subpopulation of T-helper cells that induces feedback inhibition. J Exp Med (1978) 2.53
A cellular basis for genetically controlled immunologic unresponsiveness in mice: tolerance induction in T-cells. Proc Natl Acad Sci U S A (1973) 2.52
Specialized antigen-presenting cells. Splenic dendritic cells and peritoneal-exudate cells induced by mycobacteria activate effector T cells that are resistant to suppression. J Exp Med (1982) 2.48
Induction of specific suppressor T cells in vitro. J Immunol (1976) 2.44
Determination of total and merecaptothanol-resistant antibody in the same serum sample. Clin Exp Immunol (1970) 2.36
Antigenic competition between heterologous erythrocytes. I. Thymic dependency. J Immunol (1971) 2.35
Immuno-regulatory role of spleen localizing thymocytes. J Immunol (1974) 2.27
The evolution of immunosuppressive cell populations in experimental mycobacterial infection. J Immunol (1978) 2.19
Effect of thymus-derived lymphocytes on amount and affinity of anti-hapten antibody. J Immunol (1971) 2.19
Immunoregulatory T-cell pathways. Annu Rev Immunol (1983) 2.06
Role of antigen-presenting cells in the development and persistence of contact hypersensitivity. J Exp Med (1980) 1.99
Regulation of delayed-type hypersensitivity reactions by cyclophosphamide-sensitive T cells. J Immunol (1978) 1.96
Identification of a B-cell surface structure involved in antigen-dependent triggering: absence of this structure on B cells from CBA/N mutant mice. J Exp Med (1977) 1.95
Potentiation of cultured mouse thymocyte responses by factors released by peripheral leucocytes. J Immunol (1971) 1.91
Suppressive effects of in vivo immunization on PHA responses in vitro. J Immunol (1974) 1.78
Feedback induction of suppressor T-cell activity. J Exp Med (1975) 1.78
Genetic control of immunoregulatory circuits. Genes linked to the Ig locus govern communication between regulatory T-cell sets. J Exp Med (1979) 1.77
Inactivation of thymus cells after multiple injections of antigen. Nature (1968) 1.72
Activation of suppressor T cells by tumour cells and specific antibody. Nature (1974) 1.67
T cell-dependent mast cell degranulation and release of serotonin in murine delayed-type hypersensitivity. J Exp Med (1980) 1.65
On concomitant immunity in tumour-bearing hamsters. Nature (1967) 1.59
Intermediary role of macrophages in the passage of suppressor signals between T-cell subsets. J Exp Med (1978) 1.57
The effect of localized injection of adjuvant material on the draining lymph node. 3. Thymus dependence. J Immunol (1972) 1.48
The effect of locally injected vasoactive amines on the elicitation of delayed-type hypersensitivity. J Immunol (1977) 1.45
Analysis of antigen-specific, Ig-restricted cell-free material made by I-J+ Ly-1 cells (Ly-1 TsiF) that induces Ly-2+ cells to express suppressive activity. Eur J Immunol (1981) 1.42
Immunoregulatory circuits which modulate responsiveness to suppressor cell signals: characterization of an effector cell in the contrasuppressor circuit. Eur J Immunol (1981) 1.40
Immunosuppression effected by macrophage surfaces. J Immunol (1975) 1.39
T-cell regulation of T-cell responses to antigen. Immunology (1974) 1.37
Microenvironmental immunoregulation: possible role of contrasuppressor cells in maintaining immune responses in gut-associated lymphoid tissues. Proc Natl Acad Sci U S A (1982) 1.37
Isolation and partial characterization of an antigen-specific T-cell factor associated with the suppression of delayed type hypersensitivity. Proc Natl Acad Sci U S A (1981) 1.36
Analysis of an antigen-specific H-2-restricted cell-free products(s) made by "I-J-" Ly-2 cells (Ly-2 TsF) that suppresses Ly-2 cell-depleted spleen cell activity. Eur J Immunol (1981) 1.34
Induction of suppressor cells in rat spleen: influence of microbial stimulation. J Immunol (1979) 1.31
Immunoregulatory circuits that modulate responsiveness to suppressor cell signal. Failure of B10 mice to respond to suppressor factors can be overcome by quenching the contrasuppressor circuit. J Exp Med (1981) 1.31
DNA synthetic response of thymocytes to a variety of antigens. J Immunol (1972) 1.30
Interleukin 1 can replace the requirement for I-A-positive cells in the proliferation of antigen-primed T cells. Proc Natl Acad Sci U S A (1982) 1.29
Evanescent delayed-type hypersensitivity: mediation by effector cells with a short life span. J Immunol (1977) 1.28
Thymus dependence of lymphocyte trapping. J Immunol (1974) 1.25
Transfer of an antigen-specific immediate hypersensitivity-like reaction with an antigen-binding factor produced by T cells. Proc Natl Acad Sci U S A (1982) 1.24
Ly-1 inducer and Ly-1,2 acceptor T cells in the feedback suppression circuit bear an I-J-subregion controlled determinant. Immunogenetics (1980) 1.23
T cell-mediated immunity in malaria. I. The Ly phenotype of T cells mediating resistance to Plasmodium yoelii. J Immunol (1982) 1.22
The DNA synthetic response of adoptively transferred thymocytes in the spleens of lethally irradiated mice. I. Effects of varying antigen and thymocyte doses. J Immunol (1971) 1.17
Isolation and partial characterization of antigen-binding molecules produced by in vitro 'educated' T cells. Mol Immunol (1980) 1.14
Antigen-antibody complexes generate Lyt 1 inducers of suppressor cells. J Immunol (1980) 1.11
Immunoregulatory circuits which modulate responsiveness to suppressor cell signals: contrasuppressor cells can convert an in vivo tolerogenic signal into an immunogenic one. Eur J Immunol (1981) 1.11
The response of T cells to histocompatibility-2 antigens. Dose-response kinetics. J Exp Med (1972) 1.11
Interactions between molecules (subfactors) released by different T cell sets that yield a complete factor with biological (suppressive) activity. Proc Natl Acad Sci U S A (1982) 1.11
Tolerance to sheep red cells: breakage with thymocytes and horse red cells. Science (1972) 1.09
Fever and immunoregulation. III. Hyperthermia augments the primary in vitro humoral immune response. J Exp Med (1983) 1.08
Localization of leucocytes in sites of delayed-type hypersensitivity and in lymph nodes: dependence on vasoactive amines. Immunology (1982) 1.08
Studies on homotransplantable lymphomas in hamsters. I. Histologic responses in lymphoid tissues and their relationship to metastasis. Am J Pathol (1966) 1.07
B cell-deprived mice lack functional expression of certain T suppressor cell subsets. J Mol Cell Immunol (1984) 1.06
Enhanced expression of H-2K and H-2D antigens on reticulocytes infected with Plasmodium yoelii. Nature (1983) 1.04
Role of contrasuppression in the adoptive transfer of immunity. J Exp Med (1983) 1.04
Degeneracy of the immune response to sheep red cells. Thymic dependency. Immunology (1972) 1.03
Suppressor cells: dependence on assay conditions for functional activity. J Exp Med (1976) 1.02
Characterization of T-cell surface proteins bound by heterologous antisera to antigen-specific T-cell products. Proc Natl Acad Sci U S A (1981) 1.02
Interference with the transmission of T cell-derived messages by macrophage membranes. J Immunol (1977) 1.01
Antigenic competition between heterologous erythrocytes. II. Effect of passive antibody administration. J Immunol (1971) 1.01
Factors controlling concomitant immunity in tumor-bearing hamsters: effects of prior splenectomy and tumor removal. J Natl Cancer Inst (1969) 1.01
Lymphotoxin production by subsets of T cells. J Immunol (1980) 1.00
Production of antigen-specific contrasuppressor cells and factor, and their use in augmentation of cell-mediated immunity. J Immunol (1984) 1.00
Deficient production of a thymus-dependent high affinity antibody subset in mice (CBA/N) with an X-linked B lymphocyte defect. J Immunol (1976) 0.99
Splenic regulation of the clinical appearance of small tumors. J Immunol (1975) 0.99
Immunoregulatory circuits among T cell sets: effect of mode of immunization on determining which Lyl T cell sets will be activated. J Immunol (1979) 0.99
Immunoregulation circa 1980: some comments on the state of the art. J Allergy Clin Immunol (1980) 0.96
Studies of the induction of anti-DNA in normal mice. J Immunol (1982) 0.96
Degeneracy of the immune response to sheep red cells. Immunology (1972) 0.95
Stimulation of regulatory T cell circuits by immunoglobulin-dependent structures on activated B cells. Eur J Immunol (1980) 0.95
Studies on homotransplantable lymphomas in hamsters. II. The specificity of the histologic responses in lymphoid tissues and their relationship to metastasis. Am J Pathol (1967) 0.95
Induction of autoimmunity in normal mice by thymectomy and administration of polyclonal B cell activators: association with contrasuppressor function. Clin Exp Immunol (1983) 0.94
Regulation of lymphocyte trapping: the negative trap. J Immunol (1975) 0.94
Mechanisms of suppression in the transfer of contact sensitivity. Analysis of an I-J+ molecule required for Ly2 suppressor cell activity. J Exp Med (1983) 0.93
A non-T:non-B cell bears I-A, I-E, I-J, and Tla (Qa-1?) determinants. Immunogenetics (1981) 0.93
Nylon adherent antigen-specific rosette-forming T cells. J Exp Med (1977) 0.93
Bidirectional effects of interaction between parental thymocytes and F1 spleen cells in the production of graft vs host splenomegaly. J Immunol (1972) 0.93
Anicteric viral hepatitis. A clinicopathological follow-up study in Taiwan. N Engl J Med (1966) 0.93
The hermaphrocyte: a suppressor-helper T cell. Cold Spring Harb Symp Quant Biol (1977) 0.92
Participation of cyclophosphamide-sensitive T cells in graft-vs-host reactions. J Immunol (1976) 0.92
Functional deletion of different Ly-1 T-cell-inducer subset activities by Ly-2 suppressor T lymphocytes. Proc Natl Acad Sci U S A (1981) 0.91
Thymus-derived lymphocytes and their interactions with macrophages are required for the production of osteoclast-activating factor in the mouse. Proc Natl Acad Sci U S A (1984) 0.90
Studies on homotransplantable lymphomas in hamsters. IV. Observations on macrophages in the expression of tumor immunity. Am J Pathol (1967) 0.90
T cells in a suppressor circuit and non-T:non-B cells bear different I-J determinants. Immunogenetics (1981) 0.90
Studies on homotransplantable lymphomas in hamsters. V. The significance of immunofluorescent staining in tissues from tumor-bearing animals. Transplantation (1968) 0.89
Augmentation of the adoptive transfer of specific tumor immunity by non-specifically immunized macrophages. J Natl Cancer Inst (1973) 0.89
Cell interactions in the suppression of in vitro antibody responses. J Exp Med (1976) 0.89
Role of nonimmunized macrophages in the rejection of an allotransplanted lymphoma. J Natl Cancer Inst (1970) 0.88